A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100

OBJECTIVE: Insulin icodec is a novel once-weekly basal insulin analog. This trial investigated the efficacy and safety of icodec using different once-weekly titration algorithms. RESEARCH DESIGN AND METHODS: This was a phase 2, randomized, open-label, 16-week, treat-to-target study. Insulin-naive ad...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Diabetes Care
Glavni autori: Lingvay, Ildiko, Buse, John B., Franek, Edward, Hansen, Melissa V., Koefoed, Mette M., Mathieu, Chantal, Pettus, Jeremy, Stachlewska, Karolina, Rosenstock, Julio
Format: Artigo
Jezik:Inglês
Izdano: American Diabetes Association 2021
Teme:
Emerging Therapies: Drugs and Regimens
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8323172/
https://ncbi.nlm.nih.gov/pubmed/33875484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc20-2878
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items